P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Phase of Trial: Phase II
Latest Information Update: 25 May 2018
At a glance
- Drugs P 03277 (Primary) ; Gadobenic acid
- Indications CNS disorders
- Focus Diagnostic use
- Sponsors Guerbet
- 24 Mar 2018 This trial has been completed in Belgium (End date: 2018-01-23).
- 19 Mar 2018 Status changed from recruiting to completed.
- 06 Mar 2018 This study has been completed in Hungary (end date of the trial : 2018-01-23 ) as per European Clinical Trials Database record.